Bottom line
PCHSX vs JDOC: the short answer
PCHSX (Putnam Global Health Care Fund) and JDOC (JPMorgan Healthcare Leaders ETF) are both mutual funds.
JDOC is cheaper at 0.65% vs 1.79% — a difference of $114 a year per $10,000 invested.
Over one year, JDOC returned +14.9% vs −0.4% for PCHSX (reporting dates differ).
Updated Nov 19, 2026
PCHSX vs JDOC side by side
| PCHSX | JDOC | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Franklin Templeton | J.P. Morgan |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.79% | 0.65% |
| Annual cost per $10k | $179 | $65 |
| 10-yr cost on $10k (prospectus) | $1,909 | $810 |
| Max front load | 0% | None |
| 12b-1 fee | 1% | — |
| 1-yr return | −0.4% | +14.9% |
| 5-yr return (annualized) | +7.0% | — |
| 10-yr return (annualized) | +6.9% | — |
| Best quarter | — | +11.3% |
| Worst quarter | — | −11.9% |
| Net assets (fund) | $1.5B | $9.1M |
| Number of holdings | 115 | 61 |
| Portfolio turnover | 67% | 92% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
15 of PCHSX's top 25 holdings also appear in JDOC's top 25.
| Holding | PCHSX | JDOC |
|---|---|---|
| Eli Lilly & Co. | 13.15% | 7.76% |
| Johnson & Johnson | 8.46% | 4.82% |
| UnitedHealth Group, Inc. | 6.93% | 5.85% |
| AbbVie, Inc. | 6.05% | 7.85% |
| Novartis AG | 5.13% | 1.60% |
| Merck & Co., Inc. | 4.88% | 4.82% |
| AstraZeneca plc | 4.67% | 3.76% |
| Thermo Fisher Scientific, Inc. | 4.50% | 3.73% |
| Intuitive Surgical, Inc. | 4.04% | 1.93% |
| Edwards Lifesciences Corp. | 2.80% | 1.73% |
| Roche Holding AG | 2.79% | 2.82% |
| CVS Health Corp. | 2.74% | 2.83% |
| Cardinal Health, Inc. | 2.12% | 1.51% |
| Novo Nordisk A/S | 1.90% | 2.61% |
| Bristol-Myers Squibb Co. | 1.75% | 3.57% |
Source: SEC Form N-PORT
PCHSX top 10
- Eli Lilly & Co. — 13.15%
- Johnson & Johnson — 8.46%
- UnitedHealth Group, Inc. — 6.93%
- AbbVie, Inc. — 6.05%
- Novartis AG — 5.13%
- Merck & Co., Inc. — 4.88%
- AstraZeneca plc — 4.67%
- Thermo Fisher Scientific, Inc. — 4.50%
- Intuitive Surgical, Inc. — 4.04%
- Sanofi SA — 3.23%
JDOC top 10
- AbbVie, Inc. — 7.85%
- Eli Lilly & Co. — 7.76%
- UnitedHealth Group, Inc. — 5.85%
- Merck & Co., Inc. — 4.82%
- Johnson & Johnson — 4.82%
- AstraZeneca plc — 3.76%
- Thermo Fisher Scientific, Inc. — 3.73%
- Bristol-Myers Squibb Co. — 3.57%
- Abbott Laboratories — 3.11%
- CVS Health Corp. — 2.83%
FAQ
What is the difference between PCHSX and JDOC?
PCHSX (Putnam Global Health Care Fund) and JDOC (JPMorgan Healthcare Leaders ETF) are both mutual funds. JDOC is cheaper at 0.65% vs 1.79% — a difference of $114 a year per $10,000 invested.
Which is cheaper, PCHSX or JDOC?
JDOC has the lower expense ratio (0.65%).
Should I own both PCHSX and JDOC?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.